14 completed, 3 terminated, 1 recruiting. 18 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 14, Terminated 3, Recruiting 1 |
Follow Tobramycin: new trials by email Literature Review of Tobramycin trials Research Report on Tobramycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotic Loaded Cement After TKA total knee arthroplasty, Tobramycin, Gentamicin - Total Knee Arthoplasty | Phase 3 | Completed | Rothman Institute Orthopaedics | 50 | 2022-06-20 | 2024-04-30 |
| Tobramycin Injection to Prevent Infection in Open Fractures Tobramycin Injection - Wound Infection, Fractures, Open | Phase 3 | Completed | Massachusetts General Hospital | 600 | 2022-01-10 | 2026-09-16 |
| Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 Standard of care, Vancomycin and Tobramycin - Post Operative Surgical Site Infection | Phase 3 | Recruiting | Major Extremity Trauma Research Consortium | 600 | 2021-05-07 | 2026-07-22 |
| Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis Tobi Inhalant Product, Nebcin - Cystic Fibrosis | Phase 3 | Terminated | University Hospital, Lille | 23 | 2017-06-13 | 2021-09-05 |
| Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis | Phase 3 | Completed | The George Institute | 20010 | 2017-05-01 | 2023-08-14 |
| Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients Tobramycin nebulized nasally, Physiologic serum nebulized nasally - Cystic Fibrosis, Rhinosinusitis | Phase 3 | Terminated | Virginie ESCABASSE | 86 | 2017-02-16 | 2023-02-15 |
| Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures Tobramycin, Placebo: normal saline - Fractures, Open | Phase 3 | Terminated | University of Virginia | 11 | 2015-07-01 | 2023-06-15 |
| Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Loteprednol and tobramycin, Tobramycin and dexamethasone - Conjunctivitis, Keratitis | Phase 3 | Completed | Bausch & Lomb Incorporated | 357 | 2009-10-01 | 2012-02-28 |
| A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® tobramycin - Cystic Fibrosis | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 209 | 2009-09-01 | 2020-07-31 |
| A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® tobramycin / Bramitob, tobramycin / TOBI - Cystic Fibrosis | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 324 | 2009-04-01 | 2018-06-27 |
| Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. T1225, Tobramycin - Purulent Bacterial Conjunctivitis | Phase 3 | Completed | Laboratoires Thea | 286 | 2008-12-01 | 2014-10-29 |
| Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa Aztreonam for Inhalation Solution (AZLI), Tobramycin Inhalation Solution (TIS) - Cystic Fibrosis | Phase 3 | Completed | Gilead Sciences | 274 | 2008-08-01 | 2011-07-04 |
| Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin tobramycin - Pseudomonas Infections | Phase 3 | Completed | Novartis | 50 | 2008-02-01 | 2017-02-24 |
| TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension Tobramycin 0.3%/Dexamethasone 0.05%, TOBRADEX - Ocular Inflammation Associated With Blepharaconjunctivitis | Phase 3 | Completed | Alcon Research | 221 | 2007-10-01 | 2010-03-02 |
| A Bioequivalence Study of Tobradex AF Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension, Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX) - Cataract | Phase 3 | Completed | Alcon Research | 995 | 2006-04-01 | 2012-03-05 |
| A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte Prednisolone and Tobramycin, Prednisolone - Eye Infections, Postoperative Complications | Phase 3 | Completed | Bausch & Lomb Incorporated | 132 | 2005-07-01 | 2013-03-15 |
| Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) AzaSite, Tobramycin - Bacterial Conjunctivitis | Phase 3 | Completed | Merck Sharp & Dohme LLC | 743 | 2004-07-01 | 2013-12-16 |
| Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis tobramycin - Cystic Fibrosis, Bacterial Infection | Phase 3 | Completed | FDA Office of Orphan Products Development | 200 | 1995-06-01 | 2015-03-25 |
Cystic Fibrosis (6) · Conjunctivitis (2) · Eye Infections (2) · Fractures, Open (2) · Pseudomonas Infections (2) · Bacterial Infections (1) · Blepharitis (1) · Cataract (1) · Communicable Diseases (1) · Conjunctivitis, Bacterial (1) · Critical Illness (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1) · Keratitis (1) · Lung Diseases (1)
Alcon Research (2) · Bausch & Lomb Incorporated (2) · Chiesi Farmaceutici S.p.A. (2) · FDA Office of Orphan Products Development (1) · Gilead Sciences (1) · Laboratoires Thea (1) · Major Extremity Trauma Research Consortium (1) · Massachusetts General Hospital (1) · Merck Sharp & Dohme LLC (1) · Novartis (1) · Rothman Institute Orthopaedics (1) · The George Institute (1) · University Hospital, Lille (1) · University of Virginia (1) · Virginie ESCABASSE (1)
United States (9) · France (6) · Germany (3) · Poland (2) · Spain (2) · Ukraine (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Hungary (1) · Ireland (1)
Henryk Mazurek, Doctor (2) · Alan Bruce Montgomery (1) · Anthony Gordon, MD FRCA (1) · Anthony R Carlini, MS (1) · Arun Aneja, MD, PhD (1) · Brian Cuthbertson, MD FRCA (1) · Esther Chu (1) · John Myburgh, MBBCh PhD (1) · Mark Bresnik, MD (1) · Micahel J Bosse, MD (1) · Michael Brubaker, BSN MPH (1) · Rachel Seymour, PhD (1) · Renan C Castillo, PhD (1)
PMID 24464974, PMID 17652708, PMID 21129208, PMID 22256909, PMID 22985692, PMID 23352693, PMID 24207137, PMID 26626719, PMID 35390177, PMID 36286097, PMID 37982826, PMID 38045525, PMID 41159880, PMID 42642777
2008 (1), 2014 (1)